RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance

Patients with metastatic castration-resistant prostate cancer (mCRPC) develop resistance to conventional therapies including docetaxel (DTX). Identifying molecular pathways underlying DTX resistance is critical for developing novel combinatorial therapies to prevent or reverse this resistance. To id...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cajigas-Du Ross, Christina K., Martinez, Shannalee R., Woods-Burnham, Leanne, Durán, Alfonso M., Roy, Sourav, Basu, Anamika, Ramirez, Joshua A., Ortiz-Hernández, Greisha L., Ríos-Colón, Leslimar, Chirshev, Evgeny, Sanchez-Hernandez, Evelyn S., Soto, Ubaldo, Greco, Celine, Boucheix, Claude, Chen, Xin, Unternaehrer, Juli, Wang, Charles, Casiano, Carlos A.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084384/
https://ncbi.nlm.nih.gov/pubmed/30100995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25744
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars